The genetic mutation behind Duchenne.
Understanding the cause of Duchenne begins with understanding the role of proteins and genes in how our bodies function.
Proteins are necessary for many important functions in the body, such as digesting our food, growing our bones, or—in the case of the protein called dystrophin—helping our muscles work properly.
Genes are made up of segments, called “exons,” that tell our cells which proteins to make. The dystrophin gene is made up of 79 exons that, when linked together, form the instructions for making dystrophin.
Meet Nicholas, age 17
Amenable to exon 53 skipping
What is a genetic mutation?
A mutation is a change in a person’s DNA. Mutations range in size from a small (a single rung on a ladder) to a large segment of DNA. Every mutation causes a different effect on our bodies. A mutation on the dystrophin gene means dystrophin is not produced—resulting in Duchenne.
3 common types of mutations.
One or more exons are missing
About 8% of people diagnosed with Duchenne have the genetic mutation that is amenable to VYONDYS 53. Learn what this means.
One or more exons are duplicated
Small deletions or interruptions in the instructions
The importance of genetic testing.
While there is presently no cure for Duchenne, advances in research offer hope. Genetic testing can now pinpoint the specific exons that are missing from the dystrophin gene. That’s why it’s so important for every child living with Duchenne to have a current genetic test—and for parents to understand the results.
Your child has a confirmed diagnosis of Duchenne. Have they had a genetic test?
How is a genetic test performed? Getting a genetic test is usually as simple as providing a blood or saliva sample.
To confirm a Duchenne diagnosis
To identify the genetic mutation and explore possible therapy options
To facilitate potential clinical trial participation
To assist with family planning
A doctor will need to interpret the test results to consider appropriate treatment options. Learn more about deletions.
Weekly infusions of VYONDYS 53 helped the body make a shorter form of the dystrophin protein in some boys. View the results from clinical studies.
VYONDYS 53 is used to treat patients with Duchenne muscular dystrophy (DMD) who have a confirmed mutation in the dystrophin gene that can be treated by skipping exon 53.
This indication is approved under accelerated approval based on an increase in dystrophin production in skeletal muscle observed in patients treated with VYONDYS 53. Continued approval for this indication may be contingent upon verification of a clinical benefit in confirmatory trials.